SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS ARTICLE H impact

Cramer favors Nucor and likes Simon and Federal Realty

Jim Cramer said he would not back AstraZeneca or Joby Aviation, citing missing trials and losses. He also backed Nucor, and said Simon Property Group and Federal Realty are “excellent.”

AZNJOBYRSFRTGRABNUE

On CNBC’s “ Mad Money Lightning Round,” Jim Cramer said he is not going to put his money on AstraZeneca PLC (NYSE: AZN ) because it has been missing some of its trials. As per recent news, AstraZeneca on Tuesday secured a key FDA approval for a new breast cancer treatment and reported strong Phase 3 trial data for its lung cancer and respiratory therapies. Cramer said he has been against Joby Aviation, Inc. (NYSE: JOBY ) as it has been losing money.

“It’s an interesting spec, but I would not put my money in it,” he added. On the earnings front, Joby Aviation posted mixed second-quarter results on Aug. 5 and raised its full-year guidance. Joby reported quarterly losses of 25 cents per share, missing the consensus estimate of 23 cents, according to Pro data.

Trinity Industries, Inc. (NYSE: TRN ) “shouldn’t be down this much,” Cramer said. “Now it’s at a good place. ” Trinity Industries reported mixed financial results for the second quarter on July 30.

Cramer said that although Reliance, Inc. (NYSE: RS ) is “terrific,” he prefers Nucor Corporation (NYSE: NUE ). Wells Fargo analyst Timna Tanners, on Aug. 24, maintained Reliance with an Equal-Weight rating and lowered the price target from $398 to $391.

Cramer said Simon Property Group, Inc. (NYSE: SPG ) is “so great” while he also likes Federal Realty Investment Trust (NYSE: FRT ). “Both of them are excellent,” he added. Mizuho analyst Vikram Malhorta, on Aug.

27, maintained a Neutral rating on Simon Property Group and raised the price target from $211 to $226. The Mad Money host said he has never liked Grab Holdings Limited (NASDAQ: GRAB ). On the earnings front, Grab Holdings reported better-than-expected second-quarter financial results on Aug. 4 and raised its FY26 sales guidance.

Also, the company approved a $750 million buyback. 84 on Tuesday. 31 during the session. 88 on Tuesday.

25. 01. 04. Photo via Shutterstock